Government panel recommends against allowing Serum Institute of India to conduct phase 2 & 3 clinical trials of Covavax #COVID19 vaccine on children of age 2-17 years: Sources

Government panel recommends against allowing Serum Institute of India to conduct phase 2 & 3 clinical trials of Covavax #COVID19 vaccine on children of age 2-17 years: Sources